EVARREST FIBRIN SEALANT PATCH

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-08-31 for EVARREST FIBRIN SEALANT PATCH manufactured by Omrix Biopharmaceuticals, Ltd.

Event Text Entries

[53666529] This spontaneous report from a other health professional concerns a male patient of unspecified age from the united states. The patient's weight and medical history were unknown. The patient was treated with evarrest fibrin sealant patch (batch (b)(4), expiry jul-2016). Initiated on (b)(6) 2016 for hemostasis. Concomitant medications were not reported. On (b)(6) 2016, the patient experienced expired product. The reporter stated that the subject was undergoing trauma sternotomy and lateral thoracotomy (for external trauma to the chest) for bleeding in the chest and an expired evarrest patch was used on a male patient. The patient survived the procedure and was in inpatient at the time of this report. Action taken with evarrest fibrin sealant patch was not applicable. The patient outcome was unknown for expired product. This report was not serious and reportable. This case is linked to drug/device (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2210968-2016-00888
MDR Report Key5919472
Date Received2016-08-31
Date of Report2016-08-23
Date Mfgr Received2016-08-23
Date Added to Maude2016-08-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA3
Event Location3
Manufacturer StreetUS ROUTE 22
Manufacturer CitySOMERVILLE NJ 08876
Manufacturer CountryUS
Manufacturer Postal08876
Manufacturer Phone9082180707
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameEVARREST FIBRIN SEALANT PATCH
Generic NameEVARREST FIBRIN SEALANT PATCH
Product CodeMZM
Date Received2016-08-31
Lot NumberT08F172A
Device Expiration Date2016-07-28
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerOMRIX BIOPHARMACEUTICALS, LTD
Manufacturer AddressM.D.A BLOOD BAND TEL HASHOMER, IS


Patients

Patient NumberTreatmentOutcomeDate
10 2016-08-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.